Wealthsource Partners, LLC Biogen Inc. Transaction History

Wealthsource Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $3,848 - $4,385	-15 Reduced 1.65%	894 $248,000
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $22,972 - $27,911	91 Added 11.12%	909 $251,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $159,256 - $219,600	818 New	818 $218,000
Q1 2019 May 16, 2019	SELL	$216.71 - $338.96 $154,297 - $241,339	-712 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $12,532 - $15,873	-45 Reduced 5.94%	712 $214,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $880 - $1,151	-3 Reduced 0.39%	757 $267,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $195,715 - $233,251	760 New	760 $221,000
Q1 2018 Apr 16, 2018	SELL	$260.13 - $367.91 $177,408 - $250,914	-682 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$307.64 - $344.58 $209,810 - $235,003	682	682 $217,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthsource Partners, LLC with notifications on news.